By RegMedNet –
A new clinical trial is evaluating whether a single mesenchymal stem cell infusion can stabilize cognitive decline in patients with mild cognitive impairment or early Alzheimer’s disease.
A new investigator-initiated clinical trial at the University of Miami Miller School of Medicine is exploring whether a single infusion of mesenchymal stem cells can stabilize cognitive decline in patients with mild cognitive impairment or early Alzheimer’s disease.
